Parker Flex-it Stylet Versus Malleable Stylet in Orotracheal Intubation Using a Fiber-optic Laryngoscope
NCT ID: NCT04857190
Last Updated: 2022-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2021-05-01
2022-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Background: OTI is used in general anesthesia for anesthetic delivery and ventilation of patients. OTI delay or failure may adversely affect patient outcomes, therefore, anesthetists with sufficient clinical experience and skill should perform OTI. However, in emergency situations, experienced anesthetists may not be available, and the patient may have a high Cormack-Lehane grade. A stylet is commonly used in the emergency department to aid insertion of the endotracheal tube during direct laryngoscopy.
Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 80 patients requiring OTI under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group DS, intubated using PFDS, and group MS, intubated using CMS.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube
NCT01263873
Comparison of Parker Flex-Tip Endotracheal Tube to Standard Endotracheal Tube
NCT01095861
Double Lumen Tube Positioning With Bonfils Fiberoptic Stylet: Prospective Observational Study in 30 Adult Patients
NCT03982745
Laryngeal Morbidity After Endotracheal Intubation - Endoflex-tube Versus Use of Stylet
NCT00953433
Comparison of Flex-It Stylet to Malleable Stylet for GlideScope Intubation: A Randomized Controlled Trial
NCT00771628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group DS (n=40)
Parker Flex-it Directional Stylet group
Parker Flex-it Directional Stylet
Parker Flex-it Directional Stylet
Group MS (n=40)
Conventional Malleable Stylet group
Conventional Malleable Stylet
Conventional Malleable Stylet
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parker Flex-it Directional Stylet
Parker Flex-it Directional Stylet
Conventional Malleable Stylet
Conventional Malleable Stylet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age from 21 to 60 years
* Body Mass Index (BMI) \< 35
* Mallampati classification ≤ II
Exclusion Criteria
* Age \< 21 years or \> 60 years
* Body Mass Index (BMI) ≥ 35
* Mallampati classification \> II
* Pregnant women
* Anticipated difficult airway
* Need for rapid sequence induction
* Increased risk of gastric aspiration such as gastroesophageal reflux
* Edentulous patients, Loose teeth
* Known pathology, trauma, or previous surgery to the mouth, pharynx, larynx, or cervical spine
* History of; Dysrhythmia, Hypertension, Ischemic heart disease, Hyperthyroidism, DM
21 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Damanhour Teaching Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed M Shaat, MD
Role: PRINCIPAL_INVESTIGATOR
Damanhour Teaching Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Damanhour Teaching Hospital
Damanhūr, El-Beheira, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DTH: 21001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.